New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

Dermatomyositis is a rare, type I interferon-driven autoimmune disease, which can affect muscle, skin and internal organs (especially the pulmonary system). In 2021, we have noted an increase in new-onset dermatomyositis compared to the years before the SARS-CoV-2 pandemic in our center. We present...

Descripción completa

Detalles Bibliográficos
Autores principales: Holzer, Marie-Therese, Krusche, Martin, Ruffer, Nikolas, Haberstock, Heinrich, Stephan, Marlene, Huber, Tobias B., Kötter, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Based Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358381/
https://www.ncbi.nlm.nih.gov/pubmed/35939078
http://dx.doi.org/10.1007/s00296-022-05176-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358381/
https://www.ncbi.nlm.nih.gov/pubmed/35939078
http://dx.doi.org/10.1007/s00296-022-05176-3

Ejemplares similares